Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

被引：0

作者：

Antoine Monsel

Caroline Hauw-Berlemont

Miryam Mebarki

Nicholas Heming

Julien Mayaux

Otriv Nguekap Tchoumba

Jean-Luc Diehl

Alexandre Demoule

Djillali Annane

Clémence Marois

Sophie Demeret

Emmanuel Weiss

Guillaume Voiriot

Muriel Fartoukh

Jean-Michel Constantin

Bruno Mégarbane

Gaëtan Plantefève

Stéphanie Malard-Castagnet

Sonia Burrel

Michelle Rosenzwajg

Nicolas Tchitchek

Hélène Boucher-Pillet

Guillaume Churlaud

Audrey Cras

Camille Maheux

Chloé Pezzana

Mamadou Hassimiou Diallo

Jacques Ropers

Philippe Menasché

Jérôme Larghero

机构：

[1] Assistance Publique-Hôpitaux de Paris (APHP) Sorbonne University,Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié–Salpêtrière Hospital

[2] Sorbonne Université–INSERM UMRS_959,Biotherapy (CIC

[3] Immunology–Immunopathology–Immunotherapy (I3),BTi), Hôpital Pitié

[4] APHP,Salpêtrière

[5] Université de Paris,Intensive Care Unit, APHP

[6] Université de Paris,CUP, Hôpital Européen Georges

[7] University Versailles Saint Quentin–University Paris Saclay,Pompidou

[8] APHP,APHP, Hôpital Saint

[9] Groupe Hospitalier Universitaire–Sorbonne Université,Louis, Unité de Thérapie Cellulaire, Centre d’Investigation Clinique en Biothérapies CBT501, INSERM

[10] site Pitié–Salpêtrière,FHU SEPSIS, Department of Intensive Care, Hôpital Raymond

[11] Service de Médecine Intensive et Réanimation (Département R3S),Poincaré (APHP), Laboratory of Infection & Inflammation–INSERM U1173, Simone Veil School of Medicine

[12] and Sorbonne Université,Innovative Therapies in Hemostasis, INSERM, 75006 Paris, France, and Biosurgical Research Laboratory (Carpentier Foundation), APHP

[13] INSERM,CUP, Hôpital Européen Georges

[14] UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique,Pompidou

[15] Université de Paris,Neurological Intensive Care Unit, Department of Neurology, La Pitié–Salpêtrière Hospital, APHP

[16] Sorbonne University,Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC

[17] Sorbonne Université,RESPIRE)

[18] APHP Nord,Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU PARABOL

[19] INSERM and Université de Paris,Center for Research on Inflammation

[20] Sorbonne Université,Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP

[21] University of Paris,Department of Medical and Toxicological Critical Care, Lariboisière Hospital, INSERM UMRS1144

[22] Centre Hospitalier Victor Dupouy,Service de Réanimation Polyvalente

[23] Hôpital Saint-Louis,Immunology and HLA Laboratory

[24] Sorbonne Université,INSERM U1136, Institut Pierre

[25] APHP,Louis d’Epidémiologie et de Santé Publique (iPLESP), APHP, Hôpital Pitié–Salpêtrière, Service de Virologie

[26] Hôpital Saint-Louis,INSERM UMR1140

[27] Centre MEARY de Thérapie Cellulaire et Génique,INSERM, UMR S 970, Paris Centre de Recherche Cardiovasculaire (PARCC)

[28] Université de Paris,Clinical Research Unit, Pitié–Salpêtrière University Hospital

[29] Université de Paris,Department of Cardiovascular Surgery

[30] APHP,Multidisciplinary Intensive Care Unit, Department of Anesthesiology–Critical Care and Perioperative Medicine

[31] Hôpital Européen Georges-Pompidou,Internal Use Pharmacy Department, REQPHARM Unit, La Pitié–Salpêtrière Hospital

[32] Hôpital de la Pitié–Salpêtrière,Clinical Investigation Center (CIC) at La Pitié–Salpêtrière Hospital, Assistance Publique

[33] Assistance Publique-Hôpitaux de Paris (APHP) Sorbonne University,Hôpitaux de Paris (APHP)

[34] Sorbonne University,undefined

来源：

Critical Care | / 26卷

关键词：

Severe acute respiratory syndrome coronavirus-2; Acute respiratory distress syndrome; Umbilical cord-derived mesenchymal stromal cells; Good-manufacturing practice;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
Monsel, Antoine
Hauw-Berlemont, Caroline
Mebarki, Miryam
Heming, Nicholas
Mayaux, Julien
Tchoumba, Otriv Nguekap
Diehl, Jean-Luc
Demoule, Alexandre
Annane, Djillali
Marois, Clemence
Demeret, Sophie
Weiss, Emmanuel
Voiriot, Guillaume
Fartoukh, Muriel
Constantin, Jean-Michel
Megarbane, Bruno
Plantefeve, Gaetan
Malard-Castagnet, Stephanie
Burrel, Sonia
Rosenzwajg, Michelle
Tchitchek, Nicolas
Boucher-Pillet, Helene
Churlaud, Guillaume
Cras, Audrey
Maheux, Camille
Pezzana, Chloe
Diallo, Mamadou Hassimiou
Ropers, Jacques
Menasche, Philippe
Larghero, Jerome
CRITICAL CARE, 2022, 26 (01)
[2] Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life
Sitbon, Alexandre
Hauw-Berlemont, Caroline
Mebarki, Miryam
Heming, Nicholas
Mayaux, Julien
Diehl, Jean-Luc
Demoule, Alexandre
Annane, Djillali
Marois, Clemence
Demeret, Sophie
Weiss, Emmanuel
Voiriot, Guillaume
Fartoukh, Muriel
Constantin, Jean-Michel
Megarbane, Bruno
Plantefeve, Gaetan
Boucher-Pillet, Helene
Churlaud, Guillaume
Cras, Audrey
Maheux, Camille
Pezzana, Chloe
Diallo, Mamadou Hassimiou
Lebbah, Said
Ropers, Jacques
Salem, Joe-Elie
Straus, Christian
Menasche, Philippe
Larghero, Jerome
Monsel, Antoine
STEM CELL RESEARCH & THERAPY, 2024, 15 (01) : 109
[3] Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi
Mohammad Amin Shahrbaf
Masoumeh Nouri
Faezeh Shekari
Seyedeh-Esmat Hosseini
Seyed-Mohammad Reza Hashemian
Rasoul Aliannejad
Hamidreza Jamaati
Naghmeh Khavandgar
Hediyeh Alemi
Hoda Madani
Abdoreza Nazari
Azadeh Amini
Seyedeh Nafiseh Hassani
Fatemeh Abbasi
Neda Jarooghi
Nasrin Fallah
Leila Taghiyar
Meysam Ganjibakhsh
Ensiyeh Hajizadeh-Saffar
Massoud Vosough
Hossein Baharvand
Stem Cell Research & Therapy, 14
[4] Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Zarrabi, Morteza
Shahrbaf, Mohammad Amin
Nouri, Masoumeh
Shekari, Faezeh
Hosseini, Seyedeh-Esmat
Hashemian, Seyed-Mohammad Reza
Aliannejad, Rasoul
Jamaati, Hamidreza
Khavandgar, Naghmeh
Alemi, Hediyeh
Madani, Hoda
Nazari, Abdoreza
Amini, Azadeh
Hassani, Seyedeh Nafiseh
Abbasi, Fatemeh
Jarooghi, Neda
Fallah, Nasrin
Taghiyar, Leila
Ganjibakhsh, Meysam
Hajizadeh-Saffar, Ensiyeh
Vosough, Massoud
Baharvand, Hossein
STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
[5] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Alpha-1 Antitrypsin for ARDS Secondary to Severe COVID-19
Mcelvaney, O.
McEvoy, N.
Boland, F.
Mcelvaney, O. F.
Hogan, G.
Donnelly, K.
Friel, O.
Clarke, J.
Fraughen, D.
Murphy, M. P.
Carroll, T. P.
Geoghegan, P.
Martin-Loeches, I.
Mcelvaney, N. G.
Curley, G. F.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[6] Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis
Jenks, Jeffrey D.
Hoenigl, Martin
Thompson III, George R.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 39
[7] Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
Shahbaznejad, Leila
Davoudi, Alireza
Eslami, Gohar
Markowitz, John S.
Navaeifar, Mohammad Reza
Hosseinzadeh, Fatemeh
Movahedi, Faeze Sadat
Rezai, Mohammad Sadegh
CLINICAL THERAPEUTICS, 2021, 43 (06) : 1007 - 1019
[8] Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID-19: A double-blind randomized controlled clinical trial
Zamanian, Mohammad Hossein
Norooznezhad, Amir Hossein
Hosseinkhani, Zohreh
Hassaninia, Daryoush
Mansouri, Feizollah
Vaziri, Siavash
Payandeh, Mehrdad
Heydarpour, Fatemeh
Kiani, Sara
Shirvani, Maria
Rajati, Mojgan
Bakhtiari, Mitra
Esmaili, Farzaneh
Yarani, Reza
Mansouri, Kamran
JOURNAL OF EXTRACELLULAR VESICLES, 2024, 13 (07)
[9] Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
Roozbeh, Fatemeh
Saeedi, Majid
Alizadeh-Navaei, Reza
Hedayatizadeh-Omran, Akbar
Merat, Shahin
Wentzel, Hannah
Levi, Jacob
Hill, Andrew
Shamshirian, Amir
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (03) : 753 - 757
[10] LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
Guardia, Carlos G.
Huang, Yuh-Chin T.
Morris, Peter E.
Simoson, Steven G.
Simmons, Phillip D.
CHEST, 2022, 162 (04) : 938A - 938A

← 1 2 3 4 5 →